| Literature DB >> 23172343 |
Erika Fazito1, Paloma Cuchi, Mary Mahy, Tim Brown.
Abstract
BACKGROUND: The objective of this paper is to review literature in order to calculate regional estimates of the average duration of time individuals maintain a specific high-risk behaviour.Entities:
Mesh:
Year: 2012 PMID: 23172343 PMCID: PMC3512397 DOI: 10.1136/sextrans-2012-050647
Source DB: PubMed Journal: Sex Transm Infect ISSN: 1368-4973 Impact factor: 3.519
Figure 1HIV prevalence (%) in the injecting drug users (IDU) population by year and turnover input, Thailand.
Regional estimates of duration of risk behaviour for FSW by the method of calculation
| Region | Duration of risk behaviour for female sex workers | ||
|---|---|---|---|
| First method of calculation: based on time from beginning of sex work until death or cessation | Second method of calculation: based on percentage of FSW who started selling sex in the last year | Third method of calculation: based on the median/mean time spent in sex work up to the moment of the study* | |
| Africa | NA | 5.5 (4)† | 5.5 (43) |
| Asia | NA | 2.9 (12)† | 2.8–4.0 (31) |
| Australia/Oceania | NA | NA | NA |
| North America (studies conducted in the USA) | NA | NA | 10.2–11.0 (3)† |
| Europe | NA | NA | 8.4–10.0 (10)† |
| Latin America (studies conducted in Mexico, Brazil and Peru) | NA | NA | 11.2–12.0 (6)† |
(1) In parenthesis, number of datasets used for calculation.
*Considering the median equals mean (primarily the median and, in its absence, the mean).
†Best estimate for the population.
NA, not available.
Regional estimates of duration of risk behaviour for MCFSW by the method of calculation
| Region | Duration of risk behaviour for MCFSW | ||
|---|---|---|---|
| First method of calculation: based on time from beginning of risk behaviour until death or cessation | Second method of calculation: based on percentage of MCFSW who started paying for sex in the last year | Third method of calculation: based on the median/mean time clients spent paying for sex up to the moment of the study* | |
| Africa | NA | 4.6 (1)† | 5.5 (2) |
| Asia/ Oceania | NA | NA | 32.4 (3)† |
| Europe | NA | NA | NA |
| America | NA | NA | 16.2 (3)† |
(1) In parenthesis, number of datasets used for calculation.
*Considering the median equals mean (primarily the median and, in its absence, the mean).
†Best estimate for the population.
NA, not available.
Regional estimates of duration of risk behaviour for IDU by the method of calculation
| Region | Duration of risk behaviour | ||
|---|---|---|---|
| First method of calculation: based on time from beginning of drug injection until cessation | Second method of calculation: based on percentage of IDU who started drug injection in the last year | Third method of calculation: based on the median/mean time spent in drug injection up to the moment of the study* | |
| Africa | NA | 5.6 (1) | 5.6 (1) |
| Asia | NA | 8.7 (6) | 8.8–13.6 (17) |
| Oceania | 17.0 (1)† | 5.2 (1) | 16.0–18.2 (13) |
| North America | 9.5 (1)† | 4.7 (5) | 8.8–14.0 (33) |
| Europe | 13.9 (1)† | 8.9 (4) | 17.2 (32) |
| South America | NA | NA | 19.6–21.0 (9) |
The number of datasets used for each calculation are given in parenthesis.
*Considering the median equals mean (primarily the median and in its absence the mean).
†Best estimate for the population.
NA, not available.